Progress in Radiopharmacy: Developments in Nuclear Medicine, cartea 10
Editat de P.H. Cox, Steven J. Mather, C.B. Sampson, C.R. Lazarusen Limba Engleză Hardback – 31 oct 1986
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2009.49 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 3 noi 2011 | 2009.49 lei 6-8 săpt. | |
Hardback (1) | 3031.94 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 31 oct 1986 | 3031.94 lei 6-8 săpt. |
Din seria Developments in Nuclear Medicine
- 5% Preț: 346.15 lei
- 5% Preț: 1041.90 lei
- 5% Preț: 356.43 lei
- 5% Preț: 2005.88 lei
- 5% Preț: 354.09 lei
- 5% Preț: 1343.93 lei
- 5% Preț: 1338.54 lei
- 5% Preț: 618.29 lei
- 5% Preț: 350.26 lei
- 5% Preț: 679.58 lei
- 5% Preț: 673.11 lei
- 5% Preț: 348.37 lei
- 5% Preț: 673.81 lei
- 5% Preț: 2017.97 lei
- 5% Preț: 1338.49 lei
- 5% Preț: 677.61 lei
- 5% Preț: 1039.31 lei
- 5% Preț: 677.33 lei
- 5% Preț: 1046.94 lei
- 5% Preț: 349.04 lei
- 5% Preț: 670.86 lei
- 5% Preț: 1036.19 lei
- 5% Preț: 344.16 lei
- 5% Preț: 1040.04 lei
- 5% Preț: 1039.48 lei
- 5% Preț: 1041.19 lei
- 5% Preț: 1038.12 lei
- 5% Preț: 684.21 lei
- 5% Preț: 363.38 lei
- 5% Preț: 342.99 lei
- 5% Preț: 356.69 lei
- 15% Preț: 557.00 lei
- 5% Preț: 359.91 lei
- 5% Preț: 355.66 lei
- 5% Preț: 349.73 lei
Preț: 3031.94 lei
Preț vechi: 3191.52 lei
-5% Nou
Puncte Express: 4548
Preț estimativ în valută:
580.36€ • 624.00$ • 483.82£
580.36€ • 624.00$ • 483.82£
Carte tipărită la comandă
Livrare economică 19 decembrie 24 - 02 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780898388237
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Generator Systems for Ultra-Short-Lived Radionuclides.- Generators for ultra-short-lived radionuclides. Their potential and limitations.- The current status of the Os-191?Ir-191m generator.- Pharmaceutical aspects of Krypton-81m generators.- The Yttrium-87/Strontium-87m generator. A new approach to its preparation.- II. Positron Emitting Radiopharmaceuticals.- Positrons from generators.- Production of positron emitting radionuclides using cyclotrons.- III. Radiochemistry.- Cu(I) supported isotopic exchange of arylbound iodide, new future for fast high yield labelling.- Iodine labelled 5-iodo-2-thiouracil as a melanoma seeking agent: a potential drug for diagnosis and treatment.- The synthesis and biodistribution of a radioiodinated GM1 ganglioside derivative.- Advances in radiochemistry of Tc-99m.- New aspects of complexation of technetium with DTPA ligand.- Indium chemistry in radiopharmaceutical development.- New radiohalogenation: an overview.- IV. Recent Developments in Radiopharmacy Practice.- Computers in radiopharmacy.- New developments in radiopharmacy. Dispensing techniques.- Radiopharmacy information and reporting systems. An overview.- Training and education of pharmacists for radiopharmacy.- Quality control of radiopharmaceuticals: Recent developments in analytical techniques.- A multicentre evaluation of techniques for determination of the radiochemical purity of Tc99m-DTPA.- Implications of new imaging techniques for radiopharmacy.- V. Biological Fate of Radiopharmaceuticals.- Biological fate of renal agents.- Tc99m bone seeking phosphate compounds: Studies on in vivo and in vitro behaviour.- Colloids for functional studies of the reticuloendothelial system. Quality control and biological behaviour.- In vivo behaviour of radiopharmaceuticals formyocardial imaging and metabolic studies.- Incorporation dosimetry of I-131-meta-iodobenzylguanidine (I-131-MIBG).- VI. Radionuclides in Drug Formulation Studies.- Radionuclides in drug formulation studies.- Syringe extractables: Effects on radiopharmaceuticals.- Radiolabelled antibodies as radiopharmaceuticals.- The radiolabelling of monoclonal antibodies with In-111 and their application in vivo for detection of thyroid metastases.- Production, quality control and clinical application of In-111-labelled anti-tumour monoclonal antibody.- Characterization of blood-borne radiolabel and detection of anti-mouse IgC antibodies in cancer patients receiving radiolabelled monoclonal antibody for diagnostic immunoscintigraphy.- Protein based radiopharmaceuticals: Applicability of polyacryl-amide gel electrophoresis in the quality control of labelled protein preparation.- VII. Radiopharmaceutical Aerosols.- Inhaled aerosols: Deposition and clearance.- Radioaerosols: Production and characteristics.- Lung perfusion then ventilation using a Tc-99m aerosol: Experiences with a commercial system.- Author index.